vs
Side-by-side financial comparison of Expensify, Inc. (EXFY) and Quipt Home Medical Corp. (QIPT). Click either name above to swap in a different company.
Quipt Home Medical Corp. is the larger business by last-quarter revenue ($49.0M vs $35.2M, roughly 1.4× Expensify, Inc.). On growth, Quipt Home Medical Corp. posted the faster year-over-year revenue change (32.3% vs -4.9%).
Expensify, Inc. is a software company that develops an expense management system for personal and business use. Expensify also offers a business credit card called the Expensify Card.
Quipt Home Medical Corp is a U.S.-based home medical equipment provider specializing in respiratory care, sleep therapy supplies, and chronic disease management products. It serves patients with long-term health conditions, partners with healthcare providers and insurance payers across operating regions to deliver accessible in-home medical solutions.
EXFY vs QIPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $35.2M | $49.0M |
| Net Profit | — | $-1.1M |
| Gross Margin | 49.2% | 53.5% |
| Operating Margin | -11.2% | 2.1% |
| Net Margin | — | -2.1% |
| Revenue YoY | -4.9% | 32.3% |
| Net Profit YoY | — | 2.9% |
| EPS (diluted) | $-0.07 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.2M | $49.0M | ||
| Q3 25 | $35.1M | $39.8M | ||
| Q2 25 | $35.8M | $35.1M | ||
| Q1 25 | $36.1M | $33.3M | ||
| Q4 24 | $37.0M | $37.1M | ||
| Q3 24 | $35.4M | — | ||
| Q2 24 | $33.3M | — | ||
| Q1 24 | $33.5M | — |
| Q4 25 | — | $-1.1M | ||
| Q3 25 | $-2.3M | $-3.5M | ||
| Q2 25 | $-8.8M | $-3.0M | ||
| Q1 25 | $-3.2M | $-3.0M | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | $-2.2M | — | ||
| Q2 24 | $-2.8M | — | ||
| Q1 24 | $-3.8M | — |
| Q4 25 | 49.2% | 53.5% | ||
| Q3 25 | 49.6% | 48.7% | ||
| Q2 25 | 51.9% | 57.6% | ||
| Q1 25 | 50.6% | 54.6% | ||
| Q4 24 | 51.0% | 52.1% | ||
| Q3 24 | 51.6% | — | ||
| Q2 24 | 56.9% | — | ||
| Q1 24 | 56.5% | — |
| Q4 25 | -11.2% | 2.1% | ||
| Q3 25 | -6.4% | -3.6% | ||
| Q2 25 | -28.9% | -5.2% | ||
| Q1 25 | -4.1% | -3.0% | ||
| Q4 24 | 1.3% | 1.2% | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | -5.3% | — |
| Q4 25 | — | -2.1% | ||
| Q3 25 | -6.6% | -8.9% | ||
| Q2 25 | -24.6% | -8.6% | ||
| Q1 25 | -8.8% | -9.1% | ||
| Q4 24 | — | -2.9% | ||
| Q3 24 | -6.2% | — | ||
| Q2 24 | -8.3% | — | ||
| Q1 24 | -11.3% | — |
| Q4 25 | $-0.07 | $-0.02 | ||
| Q3 25 | $-0.03 | $-0.07 | ||
| Q2 25 | $-0.10 | $-0.07 | ||
| Q1 25 | $-0.03 | $-0.07 | ||
| Q4 24 | $-0.03 | $-0.03 | ||
| Q3 24 | $-0.02 | — | ||
| Q2 24 | $-0.03 | — | ||
| Q1 24 | $-0.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.1M | $10.5M |
| Total DebtLower is stronger | — | $84.0M |
| Stockholders' EquityBook value | $132.7M | $113.0M |
| Total Assets | $186.0M | $280.7M |
| Debt / EquityLower = less leverage | — | 0.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.1M | $10.5M | ||
| Q3 25 | $61.5M | $12.9M | ||
| Q2 25 | $60.5M | $11.3M | ||
| Q1 25 | $59.6M | $17.1M | ||
| Q4 24 | $48.8M | $15.5M | ||
| Q3 24 | $39.2M | — | ||
| Q2 24 | $53.2M | — | ||
| Q1 24 | $49.3M | — |
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $87.6M | ||
| Q2 25 | — | $66.0M | ||
| Q1 25 | — | $71.5M | ||
| Q4 24 | — | $70.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $132.7M | $113.0M | ||
| Q3 25 | $135.7M | $112.1M | ||
| Q2 25 | $131.8M | $102.5M | ||
| Q1 25 | $134.7M | $103.6M | ||
| Q4 24 | $128.2M | $106.3M | ||
| Q3 24 | $119.9M | — | ||
| Q2 24 | $114.0M | — | ||
| Q1 24 | $106.5M | — |
| Q4 25 | $186.0M | $280.7M | ||
| Q3 25 | $186.8M | $283.3M | ||
| Q2 25 | $187.1M | $236.1M | ||
| Q1 25 | $189.2M | $244.6M | ||
| Q4 24 | $173.7M | $242.8M | ||
| Q3 24 | $176.2M | — | ||
| Q2 24 | $192.9M | — | ||
| Q1 24 | $184.8M | — |
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.2M | $8.9M |
| Free Cash FlowOCF − Capex | — | $6.9M |
| FCF MarginFCF / Revenue | — | 14.0% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $26.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.2M | $8.9M | ||
| Q3 25 | $4.2M | $9.8M | ||
| Q2 25 | $8.9M | $9.7M | ||
| Q1 25 | $4.8M | $8.9M | ||
| Q4 24 | $7.4M | $9.3M | ||
| Q3 24 | $3.7M | — | ||
| Q2 24 | $9.3M | — | ||
| Q1 24 | $3.5M | — |
| Q4 25 | — | $6.9M | ||
| Q3 25 | — | $8.0M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $7.3M | ||
| Q4 24 | — | $5.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 14.0% | ||
| Q3 25 | — | 20.0% | ||
| Q2 25 | — | 12.6% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 4.2% | ||
| Q3 25 | 0.0% | 4.6% | ||
| Q2 25 | — | 14.9% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | 0.0% | 9.9% | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
